Clinical Trial Update: Investigating the Role of Impella 2.5 System in Acutely Decompensated Chronic Heart Failure Patients [NA]

View source ↗

Summary

The clinical trial evaluating the Impella 2.5 System for acutely decompensated chronic heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Impella 2.5 System

Snippet

Sponsor: Abiomed Inc. | Conditions: Heart Failure | NA | Status: TERMINATED